Ignite Creation Date:
2024-05-06 @ 7:48 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06130384
Status:
COMPLETED
Last Update Posted:
2024-02-09
First Post:
2021-02-10
Brief Title:
Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection
Sponsor:
Wills Eye
Organization:
Wills Eye
Study Overview
Official Title:
Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this prospective interventional study is to compare post-intravitreal injection pain between eyes receiving topical bromfenac versus artificial tears as an analgesic after intravitreal injection
Detailed Description:
This proposed study is a double-masked randomized trial of adult patients receiving bilateral intravitreal injections Patient data from March 2021 to June 2022 will be collected Patient pain perception quantified using the Wong-Baker FACES and the short-form McGill Pain Questionnaire will be utilized to compare post-intravitreal injection pain between eyes receiving pre-injection bromfenac 009 ophthalmic solution versus artificial tears
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None